Peptide vaccines for hepatocellular carcinoma

Immunotherapy is a potentially attractive treatment option for patients with hepatocellular carcinoma (HCC). We have reported that glypican-3 (GPC3) is an ideal target for anticancer immunotherapy against HCC because its expression is specifically detected in > 80% of HCCs, even during the early...

Descripción completa

Detalles Bibliográficos
Autores principales: Nobuoka, Daisuke, Yoshikawa, Toshiaki, Sawada, Yu, Fujiwara, Toshiyoshi, Nakatsura, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667940/
https://www.ncbi.nlm.nih.gov/pubmed/23442593
http://dx.doi.org/10.4161/hv.22473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667940/
https://www.ncbi.nlm.nih.gov/pubmed/23442593
http://dx.doi.org/10.4161/hv.22473

Ejemplares similares